| NCT ID | NCT05295862 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Giessen |
| Condition | Stroke, Acute |
| Study Type | OBSERVATIONAL |
| Enrollment | 2,000 participants |
| Start Date | 2023-11-30 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 2,000 participants in total. It began in 2023-11-30 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of the planned study project is to assess the current situation regarding the treatment of patients with stroke. Specifically, various treatment strategies are to be associated and correlated with clinical endpoints, mortality or functional outcome in order to generate arguments for or against individual aspects of therapy. The focus will be on unresolved treatment approaches in acute therapy (e.g. periprocedural management, such as blood pressure, blood glucose, temperature, or airway management, during recanalizing therapies) as well as in secondary prevention on the stroke unit or intensive care unit, such as starting point, mode, and dosage of antithrombotic therapies.
Eligibility Criteria
Inclusion Criteria: * Age above 18 * Patient admitted for acute stroke (Stroke Unit or Intensive Care Unit) * Informed Consent Exclusion Criteria: * Inclusion criteria not met
Contact & Investigator
Tobias Braun, M.D.
PRINCIPAL INVESTIGATOR
University of Giessen
Frequently Asked Questions
Who can join the NCT05295862 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Stroke, Acute. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05295862 currently recruiting?
Yes, NCT05295862 is actively recruiting participants. Contact the research team at tobias.braun@neuro.med.uni-giessen.de for enrollment information.
Where is the NCT05295862 trial being conducted?
This trial is being conducted at Giessen, Germany.
Who is sponsoring the NCT05295862 clinical trial?
NCT05295862 is sponsored by University of Giessen. The principal investigator is Tobias Braun, M.D. at University of Giessen. The trial plans to enroll 2,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.